Health Capital Helsinki is proud to introduce its new Founding Pharma Partners initiative. Join us for an inspiring event where leading researchers and experts will share insights, and where you can explore high-impact public–private collaboration projects.
This event brings together key stakeholders across the health and life science ecosystem. It offers a unique opportunity to network, exchange ideas, and discover new collaboration opportunities at the intersection of research, healthcare, and industry.
Come to be inspired, build meaningful connections, and help shape the future of impactful health innovation!
Agenda
15:00 – 15:10 | Welcome & Opening Remarks by Marjo Berglund, Chief Financial Officer, University of Helsinki
Introducing the Founding Pharma Partners Initiative
Rauni Korolainen, Health Capital Helsinki
Setting the stage for a new era of strategic collaboration between academia, healthcare, and the pharmaceutical industry.
15:10 – 16:30 | Spotlight on High-Impact Collaboration Projects
Discover groundbreaking initiatives where research, healthcare systems, and industry are joining forces to address major health challenges.
15:10 – 15:30 | A 360° Approach to Obesity: Integrating Science, Business and Society to Tackle a Global Health Challenge
Kirsi Pietiläinen, Professor of Clinical Metabolism, University of Helsinki
Industry perspectives:
-
- Tero Saukkonen, Novo Nordisk – Positioning Finland as a leading country in obesity prevention and management
- Maria Jussila, Eli Lilly – Improving quality, equity and access in obesity care
- Krista Ketonen, Boehringer Ingelheim – Overcoming Clinical Inertia Through a Holistic View of Obesity‑Related Complications
15:30 – 15:50 | 100K Cancers: Unlocking Real-World Insights from Over 100,000 Cancer Patients
Risto Renkonen, Professor, University of Helsinki
Industry perspective:
- Taija af Hällström – Leveraging large-scale data to deepen understanding of cancer patient characteristics, comorbidities, treatments, and outcomes
Exploring how large-scale health data can generate new insights into cancer phenotypes, disease progression, treatment pathways, and patient outcomes, supporting more precise research and better care.
15:50 – 16:20 | Platform for Preventive Healthcare (P4H): Building the Future of Proactive and Personalized Care
Olli Carpen
Company perspective:
- Niilo Färkkilä, Switchpoint Bio
16:20 – 16:40 | Panel Discussion
Future Partnerships Driving Health Innovation
How can Finland strengthen its position as a global leader in health innovation through strategic partnerships?
Moderator: Sammeli Liikkanen
Closing remarks: Santtu Von Bruun, University of Helsinki
16:40 – 17:30 | Networking & Refreshments
Agenda with more speakers will be updated on our website.
